SHILPAMEDPharmaceuticals

Shilpa Medicare LtdQuarterly Results & Earnings

348.90
+0.75%
Profit Growth YoY145.65%Latest quarter
Sales Growth YoY7.61%Latest quarter
Sales CAGR 5Y7.12%5 year compound
Profit CAGR 5Y-10.82%5 year compound
📋

Quarterly Performance

YoY Profit Growth+145.65%
🔥 Exceptional growth
YoY Sales Growth+7.61%
📈 Moderate growth
OPM 5Y Average
Operating profit margin
18.80%
EPS Growth 5Y
-14.00%
Interest Coverage
Higher = safer debt servicing
4.28
ROE
4.21%
ROCE
7.82%
💡

Growth Analysis

Shilpa Medicare Ltd reported YoY profit growth of 145.65% and revenue growth of 7.61% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 7.12% and profits at -10.82% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.